Research institute
The use of multiple, potentially costly, drugs during combination therapy all contributes to the high costs in oncology. DO you know why does immunotherapy cost so much?
Singapore scientists’ discovery could hold the key to novel treatments for the symptoms of mosquito-borne diseases
Breakthrough Research to be Presented at the 2018 World Conference on Lung Cancer
Horizon Discovery Group plc, announced the launch of its Myeloid DNA Reference Standard. The first-to-market large cell-line derived myeloid cancer reference standard designed enables faster, more reliable and more cost-effective assay validation, to support the market in bringing routine testing into practice.
Dr. Meyer to lead panel of thought leaders capitalizing on region’s role as influential bioscience hub
Pioneering partners Cmed and Innovative Physics have combined forces to showcase The Real Time Medical Imaging Users Tool Kit®, which uses artificial intelligence to support secure, rapid diagnostics in clinical trials, at DPharm 2018.
License with Nationwide Children’s Hospital (NCH) through the Acquisition of Celenex (NCH Spinout)
Today the Society for Clinical Research Sites (SCRS) announced the finalists for the 2018 Site Patient Recruitment Innovation Award (SPRIA). Sponsor by Acurian, the SPRIA recognizes and honors highly successful innovative patient enrollment initiatives executed by sites.
Donor Relations will be focus of Kniazuk’s work
A paper entitled ‘Discovery of a Potent and Orally Bioavailable Cyclophilin Inhibitor Derived from the Sanglifehrin Macrocycle’ by authors from Selcia, Cypralis and Gilead has been selected as a featured article by the editors of The Journal of Medicinal Chemistry.
PRESS RELEASES